BioAtla, Inc. - stock earnings
BCAB Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -33.3 million USD | ? USD |
| 2023Q2 | -35.8 million USD | ? USD |
| 2023Q1 | -26.0 million USD | ? USD |
| 2022Q4 | -27.8 million USD | ? USD |
| 2022Q3 | -25.4 million USD | ? USD |
| 2022Q2 | -28.8 million USD | ? USD |
| 2022Q1 | -24.2 million USD | ? USD |
| 2021Q4 | -23.4 million USD | 250000 USD |
| 2021Q3 | -22.9 million USD | 150000 USD |
| 2021Q2 | -30.4 million USD | 250000 USD |
| 2021Q1 | -18.7 million USD | ? USD |
| 2020Q4 | -16.4 million USD | ? USD |
| 2020Q3 | -11.6 million USD | 150000 USD |
| 2020Q2 | -6.2 million USD | 190000 USD |
| 2020Q1 | -1.6 million USD | 89000 USD |
| 2019Q4 | -1.4 million USD | 2.2 million USD |
BCAB Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -124.1 million USD | ? USD |
| 2022 | -105.3 million USD | ? USD |
| 2021 | -95.4 million USD | 250000 USD |
| 2020 | -37.2 million USD | 429000 USD |
| 2019 | -31.4 million USD | 5.2 million USD |
| 2018 | -29.0 million USD | 10.6 million USD |
BCAB
Price: $3.16
52 week price:
Earnings Per Share: -2.58 USD
P/E Ratio: -0.93
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 285700
Market Capitalization: 150.5 million